The transient increase in [Ca2"]i in endothelial cells after stimulation with bradykinin can account for the initiation but not the sustained production of nitric oxide (NO). Therefore, we investigated whether this sustained activation of the constitutive NO synthase (cNOS) could be mediated by an increase in pHi, which is induced by an activation of the Na+-H+ exchanger rather than an increase in [Ca2"],. Cultured human endothelial cells grown on coverslips were loaded with either C.SNAFL-2 or fura 2-AM for fluorometric analysis of either pHi or [Ca2"],. NO release was assayed by the ability of effluent from endothelial cells to stimulate purified soluble guanylyl cyclase. The pH dependence of a microsomal cNOS preparation was determined by assay of L-[3H]citrulline formation from L-[3H]arginine.
pH, * bradykinin * endothelial cells shorter than that of the subsequent NO production. This observation led us to suggest that a second intracellular mechanism might be involved in the regulation of cNOS activity. Since the Na+-H+ antiporter is known to be activated in endothelial cells after stimulation with receptor-dependent agonists such as ATP8 and thrombin,9 we investigated whether sustained activation of cNOS after stimulation of endothelial cells with bradykinin could be mediated by an increase in pHi rather than an increase in [Ca ]2i. Materials and Methods Materials 5'-(and 6')-Carboxy-9-chloro-3,10-diacetoxy-spiro[7H-benzo[c]xanthene-7,1'(3'H)-isobenzofuran]-3'-one (C.SNAFL-2 diacetate) and Pluronic F-127 were purchased from Molecular Probes. lonomycin and fura 2-AM were obtained from Calbiochem-Novabiochem GmbH, and Nw-nitro-L-arginine (L-NNA) and HEPES were from Serva. M-119 medium was from GIBCO-BRL, and penicillin, streptomycin, L-glutamine, glutathione, and L(+)-ascorbic acid (Biotect protection medium) were from Biochrom. Superoxide dismutase was from Dr M. Haurand (Grunenthal), and 3-methylsulfonyl-4-piperidinobenzoyl guanidine hydrochloride (HOE 694) was kindly supplied by Hoechst. [3H]Arginine was obtained from Amersham-Buchler; NADPH, from Pharma-Waldhof; and 6R-tetrahydrobiopterin, from Dr B. Schircks Laboratories. Nigericin, N-methyl-D-glucamine, bradykinin, and all other substances were obtained from Sigma.
Cell Culture
Freshly isolated porcine aortic endothelial cells were prepared as previously described. 10 Human umbilical vein endo-thelial cells were isolated from umbilical cords as described" and were seeded either on glass coverslips (Bachofer) or in culture dishes (100 mm, Greiner) containing M-119 medium and 20% heat-inactivated fetal calf serum (Vitromex) supplemented with penicillin (50 U/mL), streptomycin (50 ,g/mL), L-glutamine (1 mmol/L), glutathione (5 mg/mL), and L(+)ascorbic acid (5 mg/mL). Since activity of the endothelial Na+-H+ antiporter decreases with time in culture, '2 pHi and [Ca2+i] were estimated by using cells grown on coverslips for 24 hours, whereas the cNOS-containing subcellular fraction was prepared from confluent cells.
Measurement of pHi
The pH-sensitive dye C.SNAFL-2 (Reference 13) was used to monitor pHi. Endothelial cells were loaded with C.SNAFL-2 by incubation with 3 ,umol/L C.SNAFL-2 diacetate in either Tyrode's solution containing (mmol/L) NaCl 132, KCl 4, CaCl2 1.6, MgCl2 0.98, NaHCO3 11.9, NaH2P04 0.36, HEPES 9.5, glucose 10, and EDTA 0.05, along with 0.3% bovine serum albumin (BSA), or HEPES-modified Tyrode's solution containing (mmol/L) NaCl 132, KCl 4, CaCi2 1, MgCl2 0.5, HEPES 9.5, and glucose 5, along with 0.3% BSA, for 70 minutes at 37°C. Cells were then washed twice, mounted in a flow chamber superfused with Tyrode's solution or HEPES-modified Tyrode's solution containing 0.3% BSA, and placed on the stage of an inverted microscope (Diaphot-TMB, Nikon). pHi was determined fluorometrically by continuous rapid alternating excitation from dual monochromators set at 555 and 510 nm (Deltascan, Photon Technology). Incident light passed through a filter block (XF29, Omega Optical) containing a dichroic mirror (585 nm) and was focused onto the sample by means of a x40 objective (Fluor 40, Nikon). Emitted light was collected by the objective, and fluorescence above 600 nm was detected by a photon-counting photomultiplier (D-104, Photon Technology). Photomultiplier digital output was collected by an IBM-compatible computer. The ratio of the fluorescence intensity (555/510 nm) permitted calculation of pHi independent of cell number, dye concentration inside the cell, or dye bleaching. At the end of each experiment, the fluorescence intensity ratio was calibrated by use of the protocol described by Thomas et al. '4 The buffer perfusing the chamber was replaced with a HEPES-Tyrode buffer of the following composition (mmol/L): NaCl 4, KCl 136, CaCl2 1, MgCl2 0.5, HEPES 9.5, and glucose 5, along with 10 gmol/L nigericin. The pH of this buffer was modified by N-methyl-D-glucamine. The K'-H+ ionophore nigericin allows equilibration of intracellular and extracellular H+ such that pHi becomes the same as the pH of the buffer. By use of this procedure, a calibration curve of fluorescence ratio versus pH was constructed for each coverslip.
Measurement of Cytosolic [Ca2"]
For the measurement of [Ca2+]i, endothelial cells were loaded with the fluorescent Ca2+-sensitive dye fura 2 by incubation with 3 gmol/L fura 2-AM and 0.025% (wtlvol) Pluronic F-127 at 37°C for 90 minutes. Thereafter, the coverslips were washed and mounted in a flow chamber as described. The [Ca2+i] was determined fluorometrically at the dual-excitation wavelengths of 340 and 380 nm. Incident light passed through a filter block (BA 480, Nikon), and emitted light (>480 nm) was directed to the photomultiplier tube as described above. At the end of each experiment, cells were superfused with a buffer containing 1.5 mmol/L Ca2' and 1 1mol/L ionomycin. After a stable 340/380 ratio was achieved (maximum [Rma.J), the buffer was changed to one containing 20 mmol/L EGTA and 1 pLmol/L ionomycin (minimum [Rmin).
The background signal was determined after addition of MnCl2 (10 mmol/L) to the perfusate, and [Ca2+]i was calculated assuming a dissociation constant for fura 2 at 37°C of 220 nmol/L by using the following relation as described by Grynkiewicz et all5: Soluble Guanylyl Cyclase Assay NO release was assayed by the ability of the superfusate from endothelial cells to stimulate purified soluble guanylyl cyclase as previously described. 16 Soluble guanylyl cyclase activity was calculated as nanomoles cGMP formed per minute and milligrams of enzyme. Preliminary experiments showed that HOE 694 had no effect on the activity of soluble guanylyl cyclase.
Subcellular Fractionation
Cells were homogenized by sonication (100 W) in ice-cold 50 mmol/L Tris-HCl buffer (pH 7.4) containing 1.15% (wtlvol) KCl, 1 mmol/L EDTA, 5 mmol/L glucose, 0.1 mmol/L DLdithiothreitol (DTT), 200 U/mL superoxide dismutase, 2 mg/L leupeptin, 2 mg/L pepstatin A, 10 mg/L trypsin inhibitor, and 44 mg/L phenylmethylsulfonyl fluoride (PMSF). Subcellular fractions were prepared by differential ultracentrifugation at 2000g for 10 minutes, 10 000g for 20 minutes, and 100 000g for 60 minutes. The 100 000g pellet (microsomes) was resuspended in 50 mmol/L Tris-HCl buffer (pH 7.4) containing 10% (vol/vol) glycerol, 0.1 mmol/L EDTA, 0.1 mmol/L DTT, 2 mg/L leupeptin, 2 mg/L pepstatin A, 10 mg/L trypsin inhibitor, and 44 mg/L PMSF.
Determination of cNOS Activity
Since L-citrulline is a stable coproduct of the L-arginine/NO pathway, cNOS activity can be determined by monitoring the terminated by the addition of 1 mL ice-cold 100 mmol/L HEPES buffer (pH 5.5) containing 10 mmol/L EGTA and 500 mg Dowex AG 50 W-X8 (counter-ion Na+) cation exchange resin (Serva) and incubated for 5 minutes at 0°C to 4°C, followed by a 5-minute centrifugation at 10 000g. L-[3H]Citrulline in the supernatant was quantified by liquid scintillation counting, and specific cNOS activity was calculated as the L-NNA-sensitive formation of L-[3H]citrulline per minute and milligram of protein. Experiments to determine the effect of pH on the Ca21 sensitivity of cNOS were performed as above, with the exception that the bis-Tris buffer contained 0.1 mmol/L EGTA, instead of 1 mmol/L EDTA, to which increasing concentrations of CaCl2 were added. Free Ca 2 in the buffer was determined by using fura 2 free-acid fluorescence.
Statistical Analysis
Unless otherwise indicated, data are expressed as mean+SEM. Statistical evaluation was performed by Student's t test for unpaired data, one-way ANOVA followed by a Bonferroni t test, or ANOVA for repeated measures where appropriate. Values of P<.05 were considered statistically significant.
Results

Effect of Bradykinin on pH;
In the presence of bicarbonate, the resting pHi in human endothelial cells loaded with the pH-sensitive fluorescent indicator C.SNAFL-2 was 7.18±0.05 (n=4). Stimulation of endothelial cells with bradykinin (10 nmol/L) induced an intracellular alkalinization (0.21±0.04 pH units above resting value, n=4), which was maintained after the removal of the agonist (Fig 1) . Preincubation Na+-H+ antiporter,17 was without effect on resting pH1 (7.16+0.04, n=4), an observation that is consistent with reports that the Na+-H+ antiporter is relatively inactive under resting conditions in the presence of bicarbonate. Stimulation of HOE 694-pretreated endothelial cells with bradykinin resulted in a slight decrease in pHi (7. 01+0.08
pH units below resting value, Fig 1) . These observations indicate that in the presence of bicarbonate, the alkalinization observed in bradykinin-stimulated endothelial cells involves activation of the Na+-H+ antiporter. Since bicarbonate is not required for activation of the Na+-H+ antiporter, subsequent experiments were performed in bicarbonate-free conditions.
In bicarbonate-free buffer, resting pHi in endothelial cells was estimated as being 7.03 +0.02 (n= 16). Stimulation of endothelial cells with bradykinin (10 nmol/L) caused a biphasic change in endothelial pHi, consisting of an initial acidification followed by a prolonged alkalinization above resting values (Fig 2, top) . The above resting values (Fig 2, middle) . These observations are in accordance with previously reported data. [18] [19] [20] Basal [Ca2+]i was similar in both the solvent-treated and HOE 694-treated groups, resting [Ca 2+]i being 67±5 nmol/L (n=6) and 65±9 nmol/L (n=6) in the presence and absence of HOE 694, respectively. The peak increase in [Ca 2+]i was, on the other hand, significantly attenuated by inhibition of the Na+-H+ antiporter (Fig  2, middle) . However, 10 minutes after beginning the infusion of bradykinin, there was no longer a difference in [Ca 2+]i between the two groups. Effect of Bradykinin on cNOS Activity The ability of the superfusate from bradykinin-stimulated endothelial cells to activate purified soluble guanylyl cyclase was used as an index of endothelial cNOS activity. In the solvent-treated group, stimulation with bradykinin (10 nmol/L) was associated with a rapid increase (14-fold, n=4, P<.001) in guanylyl cyclase activity (Fig 2, bottom) . Thereafter, the ability of superfusate to stimulate soluble guanylyl cyclase slowly decreased but remained significantly elevated (threefold, n=4, P<.005) above resting values 23 minutes after starting the infusion of bradykinin.
HOE 694 (10 ,g.mol/L) was without effect on the basal stimulation of soluble guanylyl cyclase by superfusate from endothelial cells. However, when compared with the solvent-treated group, inhibition of the Na+-H+ exchanger significantly attenuated the peak bradykinin- induced increase in enzyme activity (Fig 2, bottom) . This observation is consistent with the effect of HOE 694 on the peak Ca 2+ response to bradykinin. NO production by HOE 694-treated cells was also found to be significantly lower than that of control cells 15 to 23 minutes after starting the infusion of bradykinin. However, a difference in [Ca2+]i cannot account for the observed effects of Na+-H+ antiport inhibition on the prolonged production of NO, since [Ca 2+]i was similar in both the solvent-treated and HOE 694-treated groups 10 minutes after beginning the infusion of bradykinin.
Effect of A23187 on pH;
The A23187 (0.1 ,umol/L)-induced pHi response in bicarbonate-free buffer (Fig 3a) was similar to that of bradykinin in that it was biphasic and consisted of an initial acidification (0.20+0.05 pH units below resting values, n=3), followed by an alkalinization (0.57±0.06 pH units above resting values, n=3). After inhibition of the Na+-H+ antiporter, either by using HOE 694 ( Fig  3a) or by removing Na+ from the extracellular medium (not shown), only a decrease in pHi was observed in response to stimulation with A23187. These findings indicate that the endothelial response to A23187 also involves activation of the Na+-H+ antiporter.
Effect of A23187 on [Ca2"], In solvent-treated cells, A23187 (0.1 1£mol/L) induced a rapid initial peak in [Ca2+]1, followed by a above basal values (Fig 3b) .
In cells treated with HOE 694, the Ca2+ response to A23187 also consisted of the peak and plateau phases, although the amplitudes of both were significantly smaller than those observed in control cells. Moreover, in the continued presence of HOE 694, [Ca 2+]i rapidly returned to the control level after removal of A23187 (Fig 3b) .
Effect of A23187 on cNOS Activity
Cultured human umbilical vein endothelial cells grown in wells and pretreated for 5 minutes with either solvent or HOE 694 (10 ,umol/L) were incubated for 20 minutes in the absence or presence of A23187 (0.1 gmol/L) before harvesting and assay of intracellular cGMP, which was used as an index of NO formation. HOE 694 was without significant effect on NO formation in unstimulated cells (Fig 3c) pH Dependence of cNOS Activity The activity of the Ca2+/calmodulin-sensitive cNOS in both human and porcine endothelial cells was found to be pH sensitive in a narrow physiological range (Fig  4) . The L-citrulline assay revealed that decreasing pH from 7.0 to 6.7, which corresponds to the acid peak in bradykinin-and A23187-stimulated endothelial cells, decreased cNOS activity by a third. Increasing pH from 7.0 to 7.5, which corresponds to the peak pHi recorded during the alkaline phase of the bradykinin/A23187 response, increased cNOS activity slightly less than half. The pH optimum of both endothelial enzymes under the experimental conditions used was estimated as 7.5, and complete abolition of activity occurred on either increasing pH to 8.6 or decreasing pH to 5.6.
Since cNOS is a Ca2+-dependent enzyme, the influence of pH, on the Ca2+ sensitivity of cNOS was investigated. Although increasing pH from 6.5 to 7.5 significantly increased the activity of cNOS isolated from porcine aortic endothelial cells, as monitored by the conversion of L-[3H]arginine to L-[3H]citrulline, the Ca2+-activity curves constructed at three different pH values (6.5, 7.0, and 7.5) were almost superimposable (Fig 5a) . Note that as a result of the pH dependence of the Ca2+-EGTA interaction, it was not possible to reduce the concentration of free Ca2+ in the incubation medium below 200 nmol/L (as measured by the fura 2 free-acid technique) at pH 6.5. Removal of free Ca2+ by addition of EGTA (1 mmol/L) 5 minutes after initiation of the enzyme reaction attenuated the accumulation of L-[3H]citrulline at both pH 7.0 and pH 7.5 (Fig 5b) . Although some residual cNOS activity remained at pH 7.0, enzyme activity at pH 7.5 was immediately arrested after the addition of EGTA.
Discussion
The present study demonstrates that endothelial cells respond to stimulation by either the receptor-dependent agonist bradykinin or the calcium ionophore A23187, with a marked activation of the Na+-H+ antiporter. Therefore, the cellular response to these stimuli appears to be mediated not only by an increase in [Ca 2+], which is considered to be a key event in cell signaling, but also by changes in pHi.
The pH response to agonist-induced stimulation was investigated in both the presence and absence of bicar-bonate. Resting pHi in endothelial cells was found to be significantly higher in the presence of bicarbonate, indicating that under physiological conditions, a bicarbonate-dependent mechanism is responsible for the maintenance of the steady-state pH,. This bicarbonatedependent acid extrusion mechanism was characterized in bovine corneal endothelial cells as Na+ dependent, Cl-independent, and sensitive to inhibition by 4,4'diisothiocyanatostilbene-2,2' disulfonic acid. 21 The Na+-H+ antiporter appears to have little influence on resting pH, in the presence of bicarbonate, since the antiport inhibitor HOE 694 was without effect on resting pHi. This observation is in agreement with previously published data.1222 However, after stimulation of endothelial cells with bradykinin, the Na+-H+ antiporter appears to contribute to acid extrusion, since the prolonged intracellular alkalinization observed after the addition of bradykinin was abolished in the presence of HOE 694. Since the antiporter appeared to mediate bradykinin-stimulated changes in pHi, subsequent experiments were performed with a bicarbonate-free buffer in which HCO3 -Clexchangers were inactive.
In bicarbonate-free conditions, the changes in pH, observed after stimulation with either bradykinin or A23187 were biphasic and consisted of an initial acidification followed by a prolonged alkalinization above resting values. Similar effects have also been observed in ATP-stimulated8 and thrombin-stimulated9 endothelial cells. Intracellular acidification in endothelial cells may be related to increases in [Ca 2±]i, since the pH, response to ATP was reported to be abolished in the absence of extracellular Ca2+.8 Moreover, in vascular smooth muscle cells, the intracellular acidification observed after the addition of angiotensin II was reportedly due to an ATP-dependent unidirectional H' influx mediated by the plasma membrane Ca2±-ATPase.23 However, agonist-induced endothelial alkalinization is strictly dependent on the presence of extracellular sodium and sensitive to inhibition by analogues of amiloride8 9 and, as such, can be attributed to activation of the electroneutral Na+-H+ antiporter.
To study the effect of elevated pH1 on endothelial function, it was necessary to ensure that changes in pHi were distinct from changes in [Ca2+]i. Although without effect on basal [Ca2"]j, inhibition of the Na+-H+ antiporter significantly attenuated the bradykininand A23187-stimulated increase in [Ca21]i. Little is known about the interactions between the liberation of Ca21 from intracellular stores, transmembraneous Ca21 influx, and activity of the Na+-H+ antiporter in endothelial cells; therefore, a full explanation cannot be given for the HOE 694-induced attenuation of [Ca2+]j. However, there is increasing evidence that the presence of a fully functional Na+-H+ antiporter is a prerequisite for the influx of Ca21 following receptor-dependent stimulation of endothelial cells,9,24 suggesting a pH-sensitive step in the opening of Ca21 channels. For example, the replacement of extracellular Na+ by choline and the more widely used Na+-H+ antiport inhibitor EIPA has been reported to completely prevent Ca21 influx in thrombin-stimulated human endothelial cells.9 Such an effect in HOE 694-treated cells could account for the early attenuation of agonist-induced increases in [Ca21]j. Although HOE 694 is reported to be threefold more specific than EIPA against the Na+-H+ antiporter, no data are available concerning its effect on Ca'+ influx pathways in endothelial cells. Since a Na+-Ca'+ exchange mechanism exists in cultured endothelial cells, we cannot rule out the possibility that HOE 694 limited Ca'+ entry and efflux via Na+-Ca'+ exchange.
However, it has previously been reported that this exchanger does not influence either resting levels of [Ca'+]i or the Ca'+ response observed after the administration of bradykinin. 25 It would appear that changes in pHi play a role in intracellular signaling that cannot necessarily be attributed to effects on Ca 2 influx pathways. In bradykininstimulated endothelial cells, there was a clear dissociation between increases in pHi and [Ca2+], in that a clear intracellular alkalinization was maintained after the return of [Ca2"]i to resting levels. At the same time, endothelial production of NO was maintained at a level significantly higher than that of either unstimulated endothelial cells (pHi 7.03, in the absence of bicarbonate) or cells pretreated with HOE 694 (pHi 6.71, in the absence of bicarbonate). Therefore, rather than an increase in [Ca21i, intracellular alkalinization per se appears to be implicated in the maintenance of bradykinin-stimulated cNOS activity.
Stimulation of endothelial cells with A23187 resulted in a significant increase in NO formation, as measured 20 minutes after addition of the agonist by assay of intracellular cGMP, and was attenuated in the presence of HOE 694. However, this elevation in cGMP was associated with significant and prolonged increases in both pHi and [Ca2]i. Under these conditions, it was therefore impossible to differentiate between the effects of pHi and [Ca2]i on the activity of cNOS.
The observation that the bradykinin-induced increase in pHi coincided with maintained production of NO at resting [Ca2]i fits well with the finding that relatively small pH changes in the physiological range (from 6.7 to 7.4) markedly alter the activity of the Ca2/calmodulindependent endothelial NO synthase derived from two different species. This effect does not appear to be due to pH-induced changes in the Ca 2 sensitivity of cNOS, since the Ca2' activation curves obtained at pH 6.5, 7.0, and 7.5 were superimposable. An increase in pHi may also effect the deactivation of cNOS such that the decline in NO production lags behind the decrease in [Ca21]i; therefore, we investigated the effect of the removal of Ca 2 on cNOS activity. Addition of EGTA to the incubation medium 5 minutes after initiating the enzyme reaction at pH 7.0 significantly attenuated subsequent accumulation of L-[3H]citrulline, the coproduct of the NO pathway. The same experiment carried out at pH 7.5 resulted in complete abolition of cNOS activity. These results demonstrate that the activity of cNOS ceased within 2 minutes of complete removal of free Ca2' and are in agreement with the report that the removal of extracellular Ca 2 from thimerosal-stimulated endothelial cells immediately abolished NO release. 18 We cannot exclude the possibility that the greater Ca2+ response to bradykinin in control versus HOE 694-treated cells may result in delayed inactivation of cNOS and/or exert indirect influences on enzyme activity in intact cells. However, the results of the present study suggest that a retarded deactivation of cNOS at higher pH1 levels after the decline of [Ca'+]i to resting values is unlikely to account for the maintained activation of cNOS in bradykinin-stimulated endothelial cells. Moreover, pHi-induced changes in the Ca'+ sensitivity of cNOS appear unable to account for the differences in NO production observed in bradykinin-stimulated cells in the presence and absence of HOE 694. Therefore, a sustained alkalinization rather than a sustained increase in [Ca'+]j, as in the presence of bradykinin, may maintain the release of NO from endothelial cells. On the other hand, sustained intracellular acidification, as observed in the presence of the Na+-H+ exchange inhibitor, may curtail agonist-induced NO release.
To date, there have been only a few reports of enzymes that are highly sensitive to variations in pH within a narrow range. Known examples include phosphofructokinase, the rate-limiting enzyme in the glycolytic pathway, and the ribosomal S6 protein kinase. 26 Although it is clear from previous reports that activation of the endothelial cNOS is strictly dependent on the presence of Ca ',327 our findings suggest that alterations in pHi, at basal levels of [Ca2]1, represent a second intracellular mechanism for the regulation of cNOS activity. Such a regulatory mechanism may be of important physiological significance in shear stressinduced NO formation28 as well as after the onset of hypoxia and ischemia, states that might be associated with marked changes in pHi.
